TLR2 and neoplasm: To determine the role of the TLR2/4-MAPK pathway in the TIM-1+B cell expansion mediated by tumor-derived exosomal HMGB1, a TLR2/4 blocking reagent and MAPK inhibitors were added to the culture system.